AtriCure (ATRC) Equity Average (2011 - 2026)

AtriCure (ATRC) has 16 years of Equity Average data on file, last reported at $491.8 million in Q1 2026.

• Equity Average for Q1 2026 came in at $491.8 million, up 7.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $491.8 million (up 7.43% YoY), and the FY2025 annual result was $476.5 million, up 2.78% from the prior year.
• Equity Average rose to $491.8 million in Q1 2026 per ATRC's latest filing, from $484.2 million in the prior quarter.
• Over five years, Equity Average peaked at $491.8 million in Q1 2026 and troughed at $453.5 million in Q3 2022.
• A 5-year average of $464.3 million and a median of $461.2 million in 2024 frame the typical range for Equity Average.
• On a YoY basis, Equity Average climbed as much as 18.45% in 2022 and fell as far as 6.7% in 2022.
• A 5-year view of Equity Average shows it stood at $453.5 million in 2022, then grew by 2.42% to $464.5 million in 2023, then retreated by 0.32% to $463.0 million in 2024, then rose by 4.58% to $484.2 million in 2025, then increased by 1.57% to $491.8 million in 2026.
• Business Quant data shows ATRC's Equity Average at $491.8 million in Q1 2026, $484.2 million in Q4 2025, and $470.5 million in Q3 2025.